Tower Research Capital (TRC)’s RenovoRx RNXT Stock Holding History
Bought
Maintained
Sold
Other funds holding RNXT
ACM
BL
WANY
CPIG
Tower Research Capital (TRC)'s RNXT Position: Q2 2026 in Review
Tower Research Capital (TRC) reduced its RenovoRx (RNXT) stake by 81% in Q2 2026, selling an estimated $4.59K and leaving 1,161 shares worth $1.14K. The position accounts for ﹤0.01% of the portfolio, ranked #4882.
Tower Research Capital (TRC) first reported a position in RNXT in Q3 2021 and has held it in 19 quarters since. The position peaked at $35K in Q3 2021. 28 funds tracked by Wall St. Rank hold RNXT as of Q2 2026.
- Tower Research Capital (TRC) held 1,161 shares of RenovoRx worth $1.14K as of Q2 2026.
- Tower Research Capital (TRC) sold 5,051 RenovoRx shares in Q2 2026, an estimated $4.59K.
- RenovoRx made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4882 holding.
- Tower Research Capital (TRC) first reported a position in RenovoRx in Q3 2021 and has held it in 19 quarters since.
- Tower Research Capital (TRC)'s RenovoRx position peaked at $35K in Q3 2021.
- 28 funds tracked by Wall St. Rank held RenovoRx as of Q2 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.